PMID: 8950557Oct 1, 1996Paper

Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
M LebechE Petersen

Abstract

Classification systems and case definitions provide the foundations upon which clinical and epidemiological studies are based. The European Research Network on Congenital Toxoplasmosis acknowledged the lack of such a system or definitions within its field of interest and established a working group to address the issue. Congenital Toxoplasma gondii infection was defined as occurring in four separate patient groups: pregnant women, fetuses, infants, and individuals > 1 year of age. The likelihood of Toxoplasma gondii infection was separated into five mutually exclusive categories: definite, probable, possible, unlikely, and not infected. Inclusion within a specific category is dependent upon the case definition, which is in turn derived from criteria based on serological, parasitological, and clinical information. Notes are included within the classification not only to clarify the definitions, but also to improve the reliability and quality of diagnosis. The goal is to construct a system that encompasses all aspects of congenital toxoplasmosis, which is applicable to different countries and health services, suitable for large epidemiological studies, aids the diagnosis and management of individual cases, and lends itself to com...Continue Reading

References

Jul 1, 1992·Journal of Clinical Pathology·M H BessièresJ P Séguéla
Dec 1, 1990·Journal of Clinical Pathology·D H JoynsonB K Rawal
Sep 1, 1990·Journal of Clinical Microbiology·B R DannemannJ S Remington
Mar 2, 1985·Lancet·G DesmontsM Chartier
Feb 1, 1986·Lancet·J G KoppeH de Roever-Bonnet
Apr 1, 1989·The Journal of Infectious Diseases·K HedmanO Mäkelä
Jan 1, 1993·Scandinavian Journal of Infectious Diseases·M LebechE Petersen
Sep 15, 1994·The New England Journal of Medicine·P HohlfeldM Vidaud
Nov 1, 1993·The Journal of Infection·S O'ConnellD H Joynson

❮ Previous
Next ❯

Citations

Feb 20, 1999·Journal of Clinical Laboratory Analysis·A K FaureP Ambroise-Thomas
Mar 25, 1998·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M StronatiG Rondini
Nov 24, 2004·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·W BuffolanoK Hedman
Oct 16, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E G LagoA L Bender
Mar 10, 2001·International Journal for Parasitology·E PetersenI Reiter-Owona
Mar 6, 2003·BJOG : an International Journal of Obstetrics and Gynaecology·R GilbertUNKNOWN European Multicentre Study on Congenital Toxoplasmosis
Nov 8, 2011·Parasitology·X-J GaoZ-R Lun
Mar 31, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Andrea HotopUwe Gross
Jul 23, 2008·International Ophthalmology Clinics·Manuel Garza-LeonLourdes Arellanes-Garcia
Sep 8, 2011·International Ophthalmology Clinics·Miriam Englander, Lucy H Y Young
Dec 29, 2007·The Pediatric Infectious Disease Journal·François KiefferJacqueline Franck
Dec 3, 2009·The Pediatric Infectious Disease Journal·Muriel RabilloudFrançois Peyron
Mar 23, 2010·The Pediatric Infectious Disease Journal·Denis FilisettiErmanno Candolfi
Jan 26, 2013·The Pediatric Infectious Disease Journal·Elizabeth TorresJorge Enrique Gómez-Marín
Sep 18, 1998·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·P A JenumB Stray-Pedersen
Nov 24, 2012·Clinical and Vaccine Immunology : CVI·A R CentonzeR Fontana
Dec 15, 2012·Clinical and Vaccine Immunology : CVI·O VillardUNKNOWN French National Reference Center for Toxoplasmosis Network
Sep 28, 2012·Clinical and Vaccine Immunology : CVI·Andrea-Romana PrusaDavid C Kasper
Oct 9, 2003·Journal of Clinical Microbiology·Denis FilisettiErmanno Candolfi
Mar 21, 2006·Archives of Disease in Childhood·R GilbertM Stanford
Aug 11, 2006·The British Journal of Ophthalmology·M R StanfordR E Gilbert
Dec 1, 2006·The British Journal of Ophthalmology·Juliana L OréficeIngrid U Scott
Jun 10, 2011·PLoS Neglected Tropical Diseases·Jorge Enrique Gómez-MarinGiovanny Castaño
Feb 14, 2014·PloS One·Ericka Viana Machado CarellosUNKNOWN UFMG Congenital Toxoplasmosis Brazilian Group
Mar 29, 2003·Journal of Perinatal Medicine·Pantaleo GrecoLuigi Selvaggi
Aug 18, 2010·Clinical Ophthalmology·André Omgbwa EballeJustin Melong
Jun 13, 2009·Eye·J MelamedF Uberti
Dec 1, 2007·Expert Opinion on Medical Diagnostics·Stuart L Hazell
Sep 15, 2012·Tropical Medicine & International Health : TM & IH·Ana Dorcas de Melo InagakiMarisa Márcia Mussi-Pinhata
Jan 8, 2010·International Journal of Audiology·Marit Erna AustengBo Engdahl
Dec 30, 2014·The Journal of Infectious Diseases·Catalina AlvarezJorge Enrique Gómez-Marín
Sep 12, 2014·Journal of Perinatology : Official Journal of the California Perinatal Association·P ValentiniL Masini
Sep 14, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Andrea-Romana PrusaMichael Hayde
Sep 24, 2004·International Journal for Parasitology·François PeyronStéphane Picot
Sep 23, 2014·International Journal of Medical Microbiology : IJMM·Dirk SchlüterCarsten Lüder

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.